These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36609936)

  • 1. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
    Na YS; Kim SG; Cho SJ
    Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
    Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
    World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
    Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
    Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
    Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
    World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
    Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
    Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
    Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
    Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
    Wang X; Zhang Q; Han F; Wu Y
    Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
    [No Abstract]   [Full Text] [Related]  

  • 9. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
    Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
    World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Wu M; Feng S; Qian M; Wang S; Zhang K
    Risk Manag Healthc Policy; 2022; 15():2243-2255. PubMed ID: 36475275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.
    Yun CY; Kim N; Lee J; Lee JY; Hwang YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JW; Lee DH
    Helicobacter; 2018 Dec; 23(6):e12542. PubMed ID: 30303591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of operative link on gastritis assessment and operative link on gastric intestinal metaplasia systems for risk assessment of early gastric cancer: a case-control study.
    Huang Y; Chen J; Guo Y; Ding Z; Liang X; Zhang W; Xue H; Zhao Y; Li X; Lu H
    J Clin Pathol; 2023 Nov; ():. PubMed ID: 37989553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
    Ogutmen Koc D; Bektas S
    Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.
    Marcos-Pinto R; Carneiro F; Dinis-Ribeiro M; Wen X; Lopes C; Figueiredo C; Machado JC; Ferreira RM; Reis CA; Ferreira J; Pedroto I; Areias J
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1451-9. PubMed ID: 22548492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages.
    Kim YI; Kook MC; Cho SJ; Lee JY; Kim CG; Joo J; Choi IJ
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28940945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between
    Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
    World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer.
    Tsai YC; Hsiao WH; Yang HB; Cheng HC; Chang WL; Lu CC; Sheu BS
    Aliment Pharmacol Ther; 2013 May; 37(10):969-78. PubMed ID: 23550594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems.
    Cho SJ; Choi IJ; Kook MC; Nam BH; Kim CG; Lee JY; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1292-302. PubMed ID: 24134499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OLGA- and OLGIM-Based Staging in the Patients with Gastritis and Endoscopy Indications.
    Mansour-Ghanaei F; Joukar F; Yeganeh S; Sadeghi M; Daryakar A; Sepehrimanesh M
    Turk J Gastroenterol; 2022 Feb; 33(2):95-102. PubMed ID: 35238779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.
    Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M
    Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.